| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |